Component

Study-specific mixed-isomer CLA preparations

Context-specific entity; species, compartment and exposure are stated on each claim.

13 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Adding CLA during labeled oral nitrite administration increased plasma 12-nitro-CLA formation.

    Study-specific mixed-isomer CLA preparations → 12-Nitro-conjugated linoleic acid source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Same five-person paired coadministration study.
    limitations
    Same dataset as the 9-nitro product, not an independent replication.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    A second nitrated product was detected separately.
    primary_references
    Conjugated Linoleic Acid Modulates Clinical Responses to Oral Nitrite and Nitrate. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28739973/ · DOI 10.1161/HYPERTENSIONAHA.117.09016

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 326–332

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Same five-person paired coadministration study. · source_derived_draft · unverified_draft

    ## cla-human-nitro-12 A second nitrated product was detected separately. Adding CLA during labeled oral nitrite administration increased plasma 12-nitro-CLA formation. Model: Same five-person paired coadministration study. Limitations: Same dataset as the 9-nitro product, not an independent replication. Evidence access: Primary abstract Conjugated Linoleic Acid Modulates Clinical Responses to Oral Nitrite and Nitrate. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28739973/ · DOI 10.1161/HYPERTENSIONAHA.117.09016
    Complete structured claim and evidence

  2. Adding CLA during labeled oral nitrite administration increased plasma 9-nitro-CLA formation.

    Study-specific mixed-isomer CLA preparations → 9-Nitro-conjugated linoleic acid source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Healthy-volunteer crossover; five returned for CLA coadministration.
    limitations
    Small acute study using investigational formulations; not a dosing recommendation.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    Dietary lipid changed which nitrogen-oxide products formed.
    primary_references
    Conjugated Linoleic Acid Modulates Clinical Responses to Oral Nitrite and Nitrate. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28739973/ · DOI 10.1161/HYPERTENSIONAHA.117.09016

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 318–324

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Healthy-volunteer crossover; five returned for CLA coadministration. · source_derived_draft · unverified_draft

    ## cla-human-nitro-9 Dietary lipid changed which nitrogen-oxide products formed. Adding CLA during labeled oral nitrite administration increased plasma 9-nitro-CLA formation. Model: Healthy-volunteer crossover; five returned for CLA coadministration. Limitations: Small acute study using investigational formulations; not a dosing recommendation. Evidence access: Primary abstract Conjugated Linoleic Acid Modulates Clinical Responses to Oral Nitrite and Nitrate. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28739973/ · DOI 10.1161/HYPERTENSIONAHA.117.09016
    Complete structured claim and evidence

  3. Adding CLA inhibited conversion of 8-iso-PGF2alpha to its dinor metabolite in normal and adrenoleukodystrophy fibroblasts.

    Study-specific mixed-isomer CLA preparations → Human fibroblast isoprostane conversion to dinor metabolite source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human fibroblasts; accompanying rat experiments showed reduced dinor products.
    limitations
    Does not prove all CLA-associated isoprostane increases are harmless or unrelated to oxidation.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    A higher oxidation marker can reflect slower removal.
    primary_references
    Impairment of 8-iso-PGF(2ALPHA) isoprostane metabolism by dietary conjugated linoleic acid (CLA). · 2009 · https://pubmed.ncbi.nlm.nih.gov/19403295/ · DOI 10.1016/j.plefa.2009.02.008

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 358–364

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human fibroblasts; accompanying rat experiments showed reduced dinor products. · source_derived_draft · unverified_draft

    ## cla-isoprostane-catabolism A higher oxidation marker can reflect slower removal. Adding CLA inhibited conversion of 8-iso-PGF2alpha to its dinor metabolite in normal and adrenoleukodystrophy fibroblasts. Model: Human fibroblasts; accompanying rat experiments showed reduced dinor products. Limitations: Does not prove all CLA-associated isoprostane increases are harmless or unrelated to oxidation. Evidence access: Primary abstract Impairment of 8-iso-PGF(2ALPHA) isoprostane metabolism by dietary conjugated linoleic acid (CLA). · 2009 · https://pubmed.ncbi.nlm.nih.gov/19403295/ · DOI 10.1016/j.plefa.2009.02.008
    Complete structured claim and evidence

  4. Six months of mixed-isomer CLA produced no significant clamp-measured insulin-sensitivity difference from placebo.

    Study-specific mixed-isomer CLA preparations → Human clamp-measured insulin sensitivity in CLA trials source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Substudy of a 118-person trial; 49 entered clamp substudy and 41 completed paired clamps.
    limitations
    A nonsignificant result is not proof of equivalence or universal safety.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    Another preparation and population gave a different result.
    primary_references
    The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17031391/ · DOI 10.1038/sj.ijo.0803482

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 446–452

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Substudy of a 118-person trial; 49 entered clamp substudy and 41 completed paired clamps. · source_derived_draft · unverified_draft

    ## cla-mixed-clamp Another preparation and population gave a different result. Six months of mixed-isomer CLA produced no significant clamp-measured insulin-sensitivity difference from placebo. Model: Substudy of a 118-person trial; 49 entered clamp substudy and 41 completed paired clamps. Limitations: A nonsignificant result is not proof of equivalence or universal safety. Evidence access: Primary abstract The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17031391/ · DOI 10.1038/sj.ijo.0803482
    Complete structured claim and evidence

  5. CLA coadministration reduced labeled NO–deoxyhemoglobin formation and attenuated nitrite-associated vasodilation and platelet inhibition.

    Study-specific mixed-isomer CLA preparations → Human nitrosyl-hemoglobin formation source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Acute labeled-nitrite human study.
    limitations
    Does not quantify interactions with prescription nitrates or prove long-term harm.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    Making more nitrated lipid coincided with less of another NO response.
    primary_references
    Conjugated Linoleic Acid Modulates Clinical Responses to Oral Nitrite and Nitrate. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28739973/ · DOI 10.1161/HYPERTENSIONAHA.117.09016

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 334–340

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Acute labeled-nitrite human study. · source_derived_draft · unverified_draft

    ## cla-no-diversion Making more nitrated lipid coincided with less of another NO response. CLA coadministration reduced labeled NO–deoxyhemoglobin formation and attenuated nitrite-associated vasodilation and platelet inhibition. Model: Acute labeled-nitrite human study. Limitations: Does not quantify interactions with prescription nitrates or prove long-term harm. Evidence access: Primary abstract Conjugated Linoleic Acid Modulates Clinical Responses to Oral Nitrite and Nitrate. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28739973/ · DOI 10.1161/HYPERTENSIONAHA.117.09016
    Complete structured claim and evidence

  6. CLA increased TFF3 in human SW480 cells; PPAR-gamma antagonist GW9662 prevented this induction.

    Study-specific mixed-isomer CLA preparations → Human trefoil factor 3 / TFF3 source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human colorectal cell line, 0–2.5 micromolar CLA.
    limitations
    Pharmacological support does not identify the active isomer or prove human mucosal healing.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    A mucosal-repair protein responded through a receptor-sensitive pathway.
    primary_references
    Dietary conjugated linoleic acid activates PPARγ and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate sodium-induced colitis. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23077197/ · DOI 10.3945/jn.112.163931

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 374–380

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human colorectal cell line, 0–2.5 micromolar CLA. · source_derived_draft · unverified_draft

    ## cla-tff3 A mucosal-repair protein responded through a receptor-sensitive pathway. CLA increased TFF3 in human SW480 cells; PPAR-gamma antagonist GW9662 prevented this induction. Model: Human colorectal cell line, 0–2.5 micromolar CLA. Limitations: Pharmacological support does not identify the active isomer or prove human mucosal healing. Evidence access: Primary abstract Dietary conjugated linoleic acid activates PPARγ and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate sodium-induced colitis. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23077197/ · DOI 10.3945/jn.112.163931
    Complete structured claim and evidence

  7. CLA feeding worsened AOM/DSS tumor formation despite reducing acute DSS colitis.

    Study-specific mixed-isomer CLA preparations → Mouse AOM/DSS colorectal tumor burden source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Mouse colitis and colorectal-tumor models.
    limitations
    Opposite tumor direction to the earlier study; protocol/composition differences require comparison.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    Reducing inflammation did not guarantee cancer protection.
    primary_references
    CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30279515/ · DOI 10.1038/s41385-018-0090-8

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 390–396

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Mouse colitis and colorectal-tumor models. · source_derived_draft · unverified_draft

    ## cla-tumor-promotion Reducing inflammation did not guarantee cancer protection. CLA feeding worsened AOM/DSS tumor formation despite reducing acute DSS colitis. Model: Mouse colitis and colorectal-tumor models. Limitations: Opposite tumor direction to the earlier study; protocol/composition differences require comparison. Evidence access: Primary abstract CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30279515/ · DOI 10.1038/s41385-018-0090-8
    Complete structured claim and evidence

  8. A 1% CLA diet reduced disease and adenocarcinoma formation in Pparg-expressing mice, but not mice lacking Pparg in immune and epithelial cells.

    Study-specific mixed-isomer CLA preparations → Mouse AOM/DSS colorectal tumor burden source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Azoxymethane followed by 2% DSS; tissue-specific Pparg deletion.
    limitations
    A later AOM/DSS study found tumor promotion; see the unresolved research disagreement.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    One study found protection dependent on the regulator.
    primary_references
    Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20089779/ · DOI 10.3945/jn.109.115642

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 382–388

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Azoxymethane followed by 2% DSS; tissue-specific Pparg deletion. · source_derived_draft · unverified_draft

    ## cla-tumor-protection One study found protection dependent on the regulator. A 1% CLA diet reduced disease and adenocarcinoma formation in Pparg-expressing mice, but not mice lacking Pparg in immune and epithelial cells. Model: Azoxymethane followed by 2% DSS; tissue-specific Pparg deletion. Limitations: A later AOM/DSS study found tumor promotion; see the unresolved research disagreement. Evidence access: Primary abstract Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20089779/ · DOI 10.3945/jn.109.115642
    Complete structured claim and evidence

  9. The mixture and individual isomers reduced arachidonate-derived TXB2 formation, while platelet 12-HETE formation was not inhibited.

    Study-specific mixed-isomer CLA preparations → Human platelet thromboxane B2 formation source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human platelet radiotracer assay.
    limitations
    TXB2 is the measured readout of TXA2 formation.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    Two branches from the same fatty acid responded differently.
    primary_references
    Antiplatelet effects of conjugated linoleic acid isomers. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10320806/ · DOI 10.1016/s1388-1981(99)00055-4

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 286–292

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human platelet radiotracer assay. · source_derived_draft · unverified_draft

    ## cla-txb2 Two branches from the same fatty acid responded differently. The mixture and individual isomers reduced arachidonate-derived TXB2 formation, while platelet 12-HETE formation was not inhibited. Model: Human platelet radiotracer assay. Limitations: TXB2 is the measured readout of TXA2 formation. Evidence access: Primary abstract Antiplatelet effects of conjugated linoleic acid isomers. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10320806/ · DOI 10.1016/s1388-1981(99)00055-4
    Complete structured claim and evidence

  10. At one year, body fat mass was lower than placebo in CLA-triglyceride and free-fatty-acid groups by 8.7% and 6.9%, respectively.

    Study-specific mixed-isomer CLA preparations → Human body fat mass in CLA trials source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    180 overweight adults randomized to two formulations or olive oil.
    limitations
    These are fat-mass comparisons, not percentage-point body-fat changes or proven disease prevention.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    A longer mixed-preparation trial found a body-composition effect.
    primary_references
    Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15159244/ · DOI 10.1093/ajcn/79.6.1118

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 454–460

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · 180 overweight adults randomized to two formulations or olive oil. · source_derived_draft · unverified_draft

    ## cla-year-fat A longer mixed-preparation trial found a body-composition effect. At one year, body fat mass was lower than placebo in CLA-triglyceride and free-fatty-acid groups by 8.7% and 6.9%, respectively. Model: 180 overweight adults randomized to two formulations or olive oil. Limitations: These are fat-mass comparisons, not percentage-point body-fat changes or proven disease prevention. Evidence access: Primary abstract Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15159244/ · DOI 10.1093/ajcn/79.6.1118
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Colon-specific Pparg deletion abolished the protective effect of dietary CLA against DSS colitis.

    Mouse peroxisome proliferator-activated receptor gamma / Pparg → Mouse DSS colitis severity source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Conditional mouse deletion and matched littermate feeding study.
    limitations
    Mixture-specific animal result, not a human inflammatory-bowel-disease treatment.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    Removing the regulator removed protection in this model.
    primary_references
    Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15362034/ · DOI 10.1053/j.gastro.2004.06.049

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 366–372

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Conditional mouse deletion and matched littermate feeding study. · source_derived_draft · unverified_draft

    ## cla-colitis-deletion Removing the regulator removed protection in this model. Colon-specific Pparg deletion abolished the protective effect of dietary CLA against DSS colitis. Model: Conditional mouse deletion and matched littermate feeding study. Limitations: Mixture-specific animal result, not a human inflammatory-bowel-disease treatment. Evidence access: Primary abstract Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15362034/ · DOI 10.1053/j.gastro.2004.06.049
    Complete structured claim and evidence

  2. In-vivo neutralization of LAP-expressing cells abolished CLA-associated tumor promotion.

    Mouse TGF-beta-producing macrophages and T cells → Mouse AOM/DSS colorectal tumor burden source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Mouse antibody-intervention experiment targeting latency-associated peptide-expressing cells.
    limitations
    Not equivalent to proving that every TGF-beta signal was blocked or identifying a human treatment.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    Perturbing the TGF-beta-associated cell population changed the result.
    primary_references
    CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30279515/ · DOI 10.1038/s41385-018-0090-8

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 406–412

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Mouse antibody-intervention experiment targeting latency-associated peptide-expressing cells. · source_derived_draft · unverified_draft

    ## cla-tgf-neutralization Perturbing the TGF-beta-associated cell population changed the result. In-vivo neutralization of LAP-expressing cells abolished CLA-associated tumor promotion. Model: Mouse antibody-intervention experiment targeting latency-associated peptide-expressing cells. Limitations: Not equivalent to proving that every TGF-beta signal was blocked or identifying a human treatment. Evidence access: Primary abstract CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30279515/ · DOI 10.1038/s41385-018-0090-8
    Complete structured claim and evidence

  3. Macrophage-specific Pparg deletion abolished the CLA-associated protumorigenic effect.

    Mouse peroxisome proliferator-activated receptor gamma / Pparg → Mouse AOM/DSS colorectal tumor burden source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Conditional mouse knockout experiment.
    limitations
    Does not imply all PPAR-gamma activity promotes cancer.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    The relevant cell type mattered to the tumor response.
    primary_references
    CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30279515/ · DOI 10.1038/s41385-018-0090-8

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 398–404

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Conditional mouse knockout experiment. · source_derived_draft · unverified_draft

    ## cla-tumor-macrophage-deletion The relevant cell type mattered to the tumor response. Macrophage-specific Pparg deletion abolished the CLA-associated protumorigenic effect. Model: Conditional mouse knockout experiment. Limitations: Does not imply all PPAR-gamma activity promotes cancer. Evidence access: Primary abstract CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30279515/ · DOI 10.1038/s41385-018-0090-8
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards